Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global RNAi for Therapeutic Supply, Demand and Key Producers, 2024-2030

date 20 Feb 2024

date Medical Care

new_biaoQian RNAi for Therapeutic

The global RNAi for Therapeutic market size is expected to reach $ 2031.2 million by 2030, rising at a market growth of 41.2% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global RNAi for Therapeutic Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

new_biaoQian RNAi for Therapeutic

According to our (Global Info Research) latest study, the global RNAi for Therapeutic market size was valued at USD 181.1 million in 2023 and is forecast to a readjusted size of USD 2031.2 million by 2030 with a CAGR of 41.2% during review period.

USD3480.00

Add To Cart

Add To Cart

Global RNAi for Therapeutic Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

new_biaoQian RNAi for Therapeutic

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

USD3480.00

Add To Cart

Add To Cart

industry 20 Feb 2024

industry Medical Care

new_biaoQian RNAi for Therapeutic

The global RNAi for Therapeutic market size is expected to reach $ 2031.2 million by 2030, rising at a market growth of 41.2% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Medical Care

new_biaoQian RNAi for Therapeutic

According to our (Global Info Research) latest study, the global RNAi for Therapeutic market size was valued at USD 181.1 million in 2023 and is forecast to a readjusted size of USD 2031.2 million by 2030 with a CAGR of 41.2% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Medical Care

new_biaoQian RNAi for Therapeutic

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

USD3480.00

addToCart

Add To Cart